Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting133%
completed267%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors

NCT00580385
completed

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

NCT00161265
completed

Study to Obtain Full Thickness Bladder Tissue From Subjects Undergoing Cystectomy Surgery

NCT00577785

Clinical Trials (3)

Showing 3 of 3 trials
NCT00580385Not Applicable

Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors

Active Not Recruiting
NCT00161265

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

Completed
NCT00577785

Study to Obtain Full Thickness Bladder Tissue From Subjects Undergoing Cystectomy Surgery

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3